Predict your next investment

Etta Biotech company logo
HEALTHCARE | Medical Devices & Equipment / Device Design & Manufacturing
ettabiotech.com

See what CB Insights has to offer

Stage

Series A | Alive

About Etta Biotech

Etta Biotech is a maker of medical equipment.

Etta Biotech Headquarter Location

E-1506, 388 Ruoshui Rd Suzhou Industrial Park

Suzhou, Jiangsu,

China

Latest Etta Biotech News

JS Bio and Etta Biotech Advancing Partnership

Jan 19, 2021

JS Bio and Etta Biotech Advancing Partnership Will set up a high titer transient protein expression platform for high quality protein production. Dr. Edward Dai, Chairman and CEO of Etta Biotech (left); Dr. Luo Shun, Chairman and President of JS Bio (right) (Photo: Business Wire) Contract Pharma Staff01.19.21 Jianshun Biosciences (JS Bio) recently formed its strategic partnership with Etta Biotech to set up a high titer transient protein expression platform for high quality protein production using JS Bio’s transient transfection media. JS Bio becomes the exclusive cell culture supplier for Etta Biotech’s transient transfection high titer protein expression platform. Etta Biotech is a leading cell electroporation technology and equipment supplier. Its proprietary large-capacity flow electroporator, X-Porator F1, is one of the only two products of its kind in the world, and leads the market with its outstanding performance and customer value. Etta Biotech's F1 equipment, paired with a completed process optimization protocol, can significantly increase protein expression titer and quality with transient transfection, therefore reducing the user’s operational cost and shortening the R&D cycle. It has become the de facto standard equipment for high titer transient protein expression platforms used by many leading Chinese antibody drug pharmaceutical companies and IVD (In Vitro Diagnostics) companies since its launch in Oct. 2018. In accordance with the strategic agreement, JS Bio will provide Etta Biotech with customized cell culture media for its transient protein expression platform. The two parties also plan to join force further to build a rapid protein production platform aiming at producing gram-scale protein for R&D, e. g. molecular assessment within two weeks after receiving plasmids, to advance R&D process for antibody drug development. With its sophisticated quality and service systems, JS Bio will accelerate the application of Etta Biotech’s products in antibody drug development in the industry. “I am so glad to have the opportunity to join hands with the benchmark company in cell culture media, JS Bio,” said Dr. Edward Dai, chairman and chief executive officer, Etta Biotech. “Its cell culture media specially developed for Etta Biotech’s electroporator can further increase our customers’ protein output, and guarantee a supply of reliable cell culture medium products for Etta Biotech’s high titer protein transient expression platform. Etta Biotech, in return, will help JS Bio to expand its media market, and develop electroporation equipment capable for 100L and over transient protein expression systems, that will empower the CDMO service platform of Thousand Oaks Biopharmaceuticals Co., Ltd., JS Bio’s parent company. Making this partnership is a mutually beneficial cooperation.”   Dr. Shun Luo, chairman and president, JS Bio, said, “Presently, we and Etta Biotech have achieved great progresses in developing transient transfection platforms with high protein expression titer, and protein production systems at scale. With its excellent electroporation technology and equipment, Etta Biotech has become a world leader in its field. I feel so honored to work with Etta Biotech, and Dr. Dai. In the future, JS Bio will continue to take advantage of our customized cell culture media development capability and commercial supply capacity, to maximize our mutual benefits for Etta Biotech as well as for Thousand Oaks Biopharma, and together we will make significant contributions to the fast growing biopharmaceutical industry.” Contract Pharma Staff 01.19.21 Contract Pharma Staff 01.15.21 Contract Pharma Staff 01.15.21 Contract Pharma Staff 01.14.21 Contract Pharma Staff 01.14.21 Contract Pharma Staff 01.14.21 Contract Pharma Staff 01.13.21 Contract Pharma Staff 01.12.21 Contract Pharma Staff 01.12.21 Contract Pharma Staff 01.12.21 Contract Pharma Staff 01.11.21 Contract Pharma Staff 01.11.21 Contract Pharma Staff 01.11.21 Contract Pharma Staff 01.11.21 Contract Pharma Staff 01.11.21

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Etta Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Etta Biotech is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,872 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Etta Biotech Patents

Etta Biotech has filed 4 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Molecular biology
  • Fishing equipment
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/19/2020

4/20/2021

Fishing equipment, Molecular biology, Fluid dynamics, Fishing techniques and methods, Biotechnology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/19/2020

00/00/0000

00/00/0000

00/00/0000

Grant Date

4/20/2021

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Fishing equipment, Molecular biology, Fluid dynamics, Fishing techniques and methods, Biotechnology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.